News
All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...
Investing.com -- A senior scientist at the U.S. Centers for Disease Control and Prevention (CDC) resigned Monday, expressing concerns about how COVID-19 and RSV hospitalization data would be used by ...
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...
5h
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
Secretary of Health and Human Services Robert F. Kennedy Jr.’s decision to fire the Centers for Disease Control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results